Correlation Between Sinopharm Group and CARDINAL HEALTH

Can any of the company-specific risk be diversified away by investing in both Sinopharm Group and CARDINAL HEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinopharm Group and CARDINAL HEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinopharm Group Co and CARDINAL HEALTH, you can compare the effects of market volatilities on Sinopharm Group and CARDINAL HEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinopharm Group with a short position of CARDINAL HEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinopharm Group and CARDINAL HEALTH.

Diversification Opportunities for Sinopharm Group and CARDINAL HEALTH

0.47

Correlation Coefficient

Sinopharm Group  CARDINAL HEALTH

Very weak diversification

The 3 months correlation between Sinopharm and CARDINAL is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Sinopharm Group Co and CARDINAL HEALTH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CARDINAL HEALTH and Sinopharm Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinopharm Group Co are associated (or correlated) with CARDINAL HEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CARDINAL HEALTH has no effect on the direction of Sinopharm Group i.e., Sinopharm Group and CARDINAL HEALTH go up and down completely randomly.

Pair Corralation between Sinopharm Group and CARDINAL HEALTH

Assuming the 90 days trading horizon Sinopharm Group Co is expected to under-perform the CARDINAL HEALTH. In addition to that, Sinopharm Group is 1.48 times more volatile than CARDINAL HEALTH. It trades about -0.1 of its total potential returns per unit of risk. CARDINAL HEALTH is currently generating about 0.2 per unit of volatility. If you would invest  11,434  in CARDINAL HEALTH on October 12, 2024 and sell it today you would earn a total of  396.00  from holding CARDINAL HEALTH or generate 3.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sinopharm Group Co  vs.  CARDINAL HEALTH

Sinopharm Group

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sinopharm Group Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Sinopharm Group may actually be approaching a critical reversion point that can send shares even higher in February 2025.

CARDINAL HEALTH

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CARDINAL HEALTH are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile technical indicators, CARDINAL HEALTH unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sinopharm Group and CARDINAL HEALTH

The main advantage of trading using opposite Sinopharm Group and CARDINAL HEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinopharm Group position performs unexpectedly, CARDINAL HEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CARDINAL HEALTH will offset losses from the drop in CARDINAL HEALTH's long position.

The idea behind Sinopharm Group Co and CARDINAL HEALTH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.